-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
StockNews.com Initiates Coverage on Pro-Dex (NASDAQ:PDEX)
StockNews.com Initiates Coverage on Pro-Dex (NASDAQ:PDEX)
Research analysts at StockNews.com initiated coverage on shares of Pro-Dex (NASDAQ:PDEX – Get Rating) in a report issued on Sunday. The brokerage set a "buy" rating on the medical instruments supplier's stock.
Pro-Dex Trading Up 7.5 %
Shares of PDEX stock opened at $17.20 on Friday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.39 and a current ratio of 2.73. Pro-Dex has a 1 year low of $12.40 and a 1 year high of $26.50. The stock has a fifty day moving average of $17.08 and a two-hundred day moving average of $17.35. The firm has a market capitalization of $61.58 million, a PE ratio of 16.54 and a beta of 0.94.
Get Pro-Dex alerts:Pro-Dex (NASDAQ:PDEX – Get Rating) last announced its quarterly earnings results on Thursday, November 3rd. The medical instruments supplier reported $0.29 earnings per share (EPS) for the quarter. Pro-Dex had a return on equity of 16.75% and a net margin of 8.97%. The company had revenue of $11.09 million during the quarter.
Institutional Trading of Pro-Dex
Hedge funds and other institutional investors have recently modified their holdings of the company. Dimensional Fund Advisors LP raised its position in shares of Pro-Dex by 2.7% during the third quarter. Dimensional Fund Advisors LP now owns 58,126 shares of the medical instruments supplier's stock worth $1,030,000 after purchasing an additional 1,535 shares during the period. LSV Asset Management raised its position in shares of Pro-Dex by 13.9% during the first quarter. LSV Asset Management now owns 35,581 shares of the medical instruments supplier's stock worth $588,000 after purchasing an additional 4,346 shares during the period. JPMorgan Chase & Co. raised its position in shares of Pro-Dex by 59.2% during the first quarter. JPMorgan Chase & Co. now owns 20,863 shares of the medical instruments supplier's stock worth $345,000 after purchasing an additional 7,762 shares during the period. State Street Corp raised its position in shares of Pro-Dex by 5.8% during the first quarter. State Street Corp now owns 11,923 shares of the medical instruments supplier's stock worth $197,000 after purchasing an additional 650 shares during the period. Finally, Renaissance Technologies LLC acquired a new stake in shares of Pro-Dex during the second quarter worth $168,000. Institutional investors own 13.49% of the company's stock.About Pro-Dex
(Get Rating)
Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
Further Reading
- Get a free copy of the StockNews.com research report on Pro-Dex (PDEX)
- MarketBeat: Week in Review 01/02-01/06
- Why is the CrowdStrike Stock Price Struggling?
- Four Undervalued Healthcare Stocks for 2023
- WWE Stock: Vince McMahon Wants Back In The Show
- NVIDIA Is Bottoming But Don't Buy It Just Yet
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.
StockNews.com的研究分析師開始對以下股票進行報道Pro-Dex(納斯達克:PDEX-GET評級)在週日發佈的一份報告中。該經紀公司對這家醫療器械供應商的股票設定了“買入”評級。
Pro-Dex交易上漲7.5%
上週五,PDEX的股票開盤報17.20美元。該公司的負債權益比率為0.41,速動比率為1.39,流動比率為2.73。Pro-Dex的一年低點為12.40美元,一年高位為26.50美元。該股的50日移動均線為17.08美元,200日移動均線為17.35美元。該公司市值為6158萬美元,本益比為16.54倍,貝塔係數為0.94。
到達支持Dex警報:Pro-Dex(納斯達克:PDEX-GET Rating)上一次公佈季度收益是在11月3日(星期四)。這家醫療器械供應商公佈本季度每股收益(EPS)為0.29美元。Pro-Dex的股本回報率為16.75%,淨利潤率為8.97%。該公司本季度營收為1109萬美元。
Pro-Dex的機構交易
對沖基金和其他機構投資者最近調整了對該公司的持股。Dimension Fund Advisors LP在第三季度將其在Pro-Dex股票的持倉增加了2.7%。Dimension Fund Advisors LP在此期間額外購買了1,535股,現在擁有這家醫療器械供應商的58,126股票,價值1,030,000美元。LSV Asset Management在第一季度將其在Pro-Dex股票的持倉增加了13.9%。在此期間,LSV資產管理公司額外購買了4346股,現在擁有這家醫療器械供應商的35,581股股票,價值58.8萬美元。今年第一季度,摩根大通將Pro-Dex股票的持倉量提高了59.2%。摩根大通在此期間增持了7,762股,目前持有這家醫療器械供應商20,863股股票,價值345,000美元。道富集團在第一季度將Pro-Dex的股票頭寸提高了5.8%。道富集團目前持有這家醫療器械供應商11,923股股票,價值19.7萬美元,在此期間又購買了650股。最後,復興科技有限責任公司在第二季度收購了Pro-Dex價值16.8萬美元的新股份。機構投資者持有該公司13.49%的股份。關於Pro-Dex
(獲取評級)
Pro-Dex公司為世界各地的醫療器械原始設備製造商設計、開發、製造和銷售動力手術器械。該公司提供可高壓滅菌、電池供電和電動的多功能外科驅動程式和剃鬚刀,主要用於整形外科、胸部和顱頜面部市場。
進一步閱讀
- 免費獲取StockNews.com Pro-Dex上的研究報告(PDEX)
- MarketBeat:回顧中的一週01/02-01/06
- 為什麼CrowdStrike的股價舉步維艱?
- 2023年四隻被低估的醫療保健股票
- WWE股票:文斯·麥克馬洪想要重返節目
- NVIDIA正在觸底,但現在還不能買入
接受Pro-Dex Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Pro-Dex和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧